New York, September 2026 – Maria joins Velocity Clinical Research from Quotient Sciences, where she served as Senior Medical Director, bringing a distinguished career in clinical research and medical leadership to her new role. Prior to Quotient Sciences, Maria spent nine years as a Principal Investigator at Watson Therapeutics, developing the deep clinical trial expertise and site-level leadership experience that makes her an exceptional addition to the Velocity network.
Velocity Clinical Research is one of the largest and most respected clinical trial site organizations in the world, with a growing network of sites dedicated to connecting patients with potentially life-changing treatments across a broad range of therapeutic areas. Maria’s appointment as Principal Investigator in Los Angeles reflects Velocity’s continued commitment to attracting world-class clinical leadership across its network, and marks the beginning of what has since become a sustained and productive retained partnership with Metric.
The search was led by Oli Oldham at Metric.
Of the process, Maria Bermudez said: “I had the pleasure of working with Oli Oldham during my recruitment process with Velocity Clinical Research, and I couldn’t be more grateful for the experience. Throughout the entire process, Oli was professional, responsive, and genuinely invested in finding the right opportunity for me. From our initial conversations through the interview process and final offer, and even after I started, he kept checking in. I truly appreciated his transparency, attention to detail, and commitment to ensuring that both my professional goals and the organization’s needs were aligned. I would definitely work with him again in the future and would recommend him to anyone looking to transition in the clinical research industry.”
Speaking of the partnership, Heather Schnepf, Manager of Talent Acquisition at Velocity Clinical Research, commented: “Metric was a trusted partner during our search. They provided strong communication, quality candidates, and a collaborative approach that helped make the hiring process smooth and efficient. We truly valued the partnership.”
Speaking of the placement, Oli Oldham commented: “Placing a physician-scientist of Maria’s caliber into a site network of Velocity’s standing is exactly the kind of search that demands both precision and pace. Maria’s background, spanning nine years as a Principal Investigator at Watson Therapeutics followed by senior medical leadership at Quotient Sciences, gave her a rare combination of hands-on site experience and strategic clinical oversight that made her the standout candidate. We are proud of the partnership we have built with Velocity and look forward to continuing to support their growth.”
